DC Chemicals Limited
China
Product Name: LY-255582
Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao

119193-09-8

119193-09-8 structure

Name: LY-255582
Chemical Name: ly 255582
CAS Number: 119193-09-8
Molecular Formula: C₂₂H₃₅NO₂
Molecular Weight: 345.51900
Catalog: Signaling Pathways GPCR/G Protein Opioid Receptor
Create Date: 2017-09-04 01:18:11
Modify Date: 2024-01-12 10:08:42
LY255582 is a pan-opioid antagonist and has high affinity for mu, delta, and kappa receptors (Ki: 0.4 nM, 5.2, 2.0 nM respectively). LY255582 can decrease food intake and body weight. LY255582 can be used for the research of obesity[1][2][3][4].

Name	ly 255582
Synonyms	(+)-1-[(3S)-3-Hydroxy-3-cyclohexylpropyl]-(3R,4R)-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine (+)-1-(3(S)-3-hydroxy-3-cyclohexylpropyl)-3(R),4(R)-dimethyl-4-(3-hydroxyphenyl)piperidine

Description	LY255582 is a pan-opioid antagonist and has high affinity for mu, delta, and kappa receptors (Ki: 0.4 nM, 5.2, 2.0 nM respectively). LY255582 can decrease food intake and body weight. LY255582 can be used for the research of obesity[1][2][3][4].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Opioid Receptor Research Areas >> Metabolic Disease Signaling Pathways >> Neuronal Signaling >> Opioid Receptor
Target	μ Opioid Receptor/MOR:0.4 nM (Ki) δ Opioid Receptor/DOR:5.2 nM (Ki) κ Opioid Receptor/KOR:2.0 nM (Ki)
In Vitro	LY255582 (40 μM, 24-72 h) 抑制 Huh7 和 MHCC-97H 细胞活力[5]。
In Vivo	LY255582 (100 μg，i.c.v.) 减少大鼠的食物摄入量[1]。 LY255582 (15 mg/kg，皮下注射，每日一次) 减少喂食的肥胖 Zucker 大鼠的食物摄入量和体重增加[4]。 Animal Model: STZ-induced diabetic mice[1] Dosage: 100, 10 and 1 μg Administration: i.c.v. Result: Decreased food at 100, 10 and 1 μg by 76, 62 and 29%.
References	[1]. Levine AS, et al. Central administration of the opioid antagonist, LY255582, decreases short- and long-term food intake in rats. Brain Res. 1991 Dec 6;566(1-2):193-7. [2]. Need AB, et al. In vivo rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously. Life Sci. 2007 Oct 13;81(17-18):1389-96. [3]. S.L. Gackenheimer, et al. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: Comparison with the distribution of mu, delta and kappa binding sites. Neuropeptides. 2005. 39 (6), 559-567. [4]. Shaw WN, et al. Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants. Pharmacol Biochem Behav. 1993 Nov;46(3):653-9. [5]. Chen DT, et al. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target. Br J Anaesth. 2019 Jun;122(6):e157-e167.

Molecular Formula	C₂₂H₃₅NO₂
Molecular Weight	345.51900
Exact Mass	345.26700
PSA	43.70000
LogP	4.26090

RIDADR	NONH for all modes of transport

145678-86-0

119193-09-8

Literature: Werner, John A.; Cerbone, Louis R.; Frank, Scott A.; Ward, Jeffrey A.; Labib, Parviz; Tharp-Taylor, Roger W.; Ryan Journal of Organic Chemistry, 1996 , vol. 61, # 2 p. 587 - 597

Precursor 1
145678-86-0
DownStream 0

119193-09-8	886047-22-9
152755-31-2	172895-15-7
186544-27-4	1779796-27-8
193281-05-9	107889-32-7
137328-52-0	176199-48-7